Nutrien Ltd. (NYSE:NTR – Free Report) – Equities researchers at Zacks Research lowered their FY2024 earnings estimates for Nutrien in a report issued on Tuesday, November 19th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $3.54 for the year, down from their prior forecast of $3.76. The consensus estimate for Nutrien’s current full-year earnings is $3.56 per share. Zacks Research also issued estimates for Nutrien’s Q3 2025 earnings at $0.54 EPS.
Nutrien (NYSE:NTR – Get Free Report) last issued its quarterly earnings results on Wednesday, November 6th. The company reported $0.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.43 by ($0.04). Nutrien had a net margin of 2.79% and a return on equity of 6.99%. The firm had revenue of $5.35 billion for the quarter, compared to analyst estimates of $5.26 billion. During the same quarter last year, the business posted $0.35 earnings per share. The firm’s revenue for the quarter was down 5.0% compared to the same quarter last year.
View Our Latest Analysis on Nutrien
Nutrien Price Performance
Shares of NYSE NTR opened at $46.93 on Friday. Nutrien has a twelve month low of $44.65 and a twelve month high of $60.87. The company has a market capitalization of $23.18 billion, a price-to-earnings ratio of 31.50, a PEG ratio of 1.65 and a beta of 0.82. The firm has a 50-day moving average of $48.01 and a two-hundred day moving average of $50.15. The company has a current ratio of 1.27, a quick ratio of 0.82 and a debt-to-equity ratio of 0.38.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Silchester International Investors LLP boosted its holdings in Nutrien by 164.4% during the third quarter. Silchester International Investors LLP now owns 10,683,242 shares of the company’s stock valued at $513,437,000 after acquiring an additional 6,642,075 shares during the period. Healthcare of Ontario Pension Plan Trust Fund bought a new stake in Nutrien during the 3rd quarter valued at approximately $150,181,000. Bank of Montreal Can grew its holdings in Nutrien by 15.5% in the 2nd quarter. Bank of Montreal Can now owns 13,354,385 shares of the company’s stock valued at $719,668,000 after buying an additional 1,794,333 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd increased its position in Nutrien by 78.8% in the 3rd quarter. Clal Insurance Enterprises Holdings Ltd now owns 2,495,282 shares of the company’s stock worth $121,271,000 after buying an additional 1,100,000 shares during the period. Finally, National Bank of Canada FI increased its position in Nutrien by 34.0% in the 2nd quarter. National Bank of Canada FI now owns 4,066,629 shares of the company’s stock worth $205,385,000 after buying an additional 1,032,763 shares during the period. 63.10% of the stock is currently owned by institutional investors and hedge funds.
Nutrien Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 17th. Stockholders of record on Tuesday, December 31st will be paid a $0.939 dividend. This represents a $3.76 dividend on an annualized basis and a dividend yield of 8.00%. This is a boost from Nutrien’s previous quarterly dividend of $0.54. The ex-dividend date is Tuesday, December 31st. Nutrien’s payout ratio is presently 144.97%.
About Nutrien
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Featured Articles
- Five stocks we like better than Nutrien
- Energy and Oil Stocks Explained
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
- 3 Fintech Stocks With Good 2021 Prospects
- MarketBeat Week in Review – 11/18 – 11/22
- How to Find Undervalued Stocks
- 2 Finance Stocks With Competitive Advantages You Can’t Ignore
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.